Health Dictionary Find a Doctor

Mesoblastic nephroma

For patient information click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Synonyms and keywords: Congenital mesoblastic nephroma; Fetal renal hamartoma

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Mesoblastic nephroma is a type of kidney tumor. Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates.[1][2] The male to female ratio is approximately 2 to 1.[3] Mesoblastic nephroma may be classified according to pathology into three subtypes: classic, cellular, and mixed mesoblastic nephroma.[4] Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[5] On gross pathology, a solid nonencapsulated mass that often occurs near the renal hilum is the characteristic finding of mesoblastic nephroma. On microscopic histopathological analysis, spindle cell is the characteristic finding of classic mesoblastic nephroma; whereas, plump cells with vesicular nuclei is the characteristic finding of cellular mesoblastic nephroma.[6] Mesoblastic nephroma must be differentiated from rhabdoid tumor, clear cell sarcoma of the kidney, and Wilm’s tumor. Symptoms of mesoblastic nephroma include polyhydramnios, hematuria, and abdominal distension. Biopsy is helpful in the diagnosis of mesoblastic nephroma. The predominant therapy for mesoblastic nephroma is surgical resection. Adjunctive chemotherapy may be required for cellular mesoblastic nephroma.[4] Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[7]

Classification

Mesoblastic nephroma may be classified according to pathology into three subtypes: classic, cellular, and mixed mesoblastic nephroma.[4]

Pathophysiology

On gross pathology, a solid nonencapsulated mass that often occurs near the renal hilum is the characteristic finding of mesoblastic nephroma. On microscopic histopathological analysis, spindle cell is the characteristic finding of classic mesoblastic nephroma; whereas, plump cells with vesicular nuclei is the characteristic finding of cellular mesoblastic nephroma.[8]

Causes

Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[5]

Differential diagnosis

Mesoblastic nephroma must be differentiated from rhabdoid tumor, clear cell sarcoma of the kidney, and Wilm’s tumor.

Epidemiology and Demographics

Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates. [1][9] The male to female ratio is approximately 2 to 1.[3]

Risk Factors

There are no established risk factors for mesoblastic nephroma.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for mesoblastic nephroma.[10]

Complications and Prognosis

Complications of mesoblastic nephroma include stillbirth, shoulder dystocia at birth, hydrops fetalis, and respiratory distress syndrome. Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[7]

Staging

There is no established system for the staging of mesoblastic nephroma.

Diagnosis

Symptoms

Symptoms of mesoblastic nephroma include polyhydramnios, hematuria, and abdominal distension.

Physical Examination

Common physical examination findings of mesoblastic nephroma include pallor and an palpated abdominal mass.

Laboratory Findings

There are no laboratory findings associated with mesoblastic nephroma.

X Ray

Abdominal X-ray may be helpful in the diagnosis of mesoblastic nephroma.

CT Scan

CT scan may be helpful in the diagnosis of mesoblastic nephroma.

MRI

MRI may be helpful in the diagnosis of mesoblastic nephroma.

Ultrasound

Ultrasound may be helpful in the diagnosis of mesoblastic nephroma.

Other Imaging Findings

There are no other imaging findings associated with mesoblastic nephroma.

Other Diagnostic Studies

There are no other diagnostic study findings associated with mesoblastic nephroma.

Biopsy

Biopsy is helpful in the diagnosis of mesoblastic nephroma.

Treatment

Medical Therapy

The predominant therapy for mesoblastic nephroma is surgical resection. Adjunctive chemotherapy may be required for cellular mesoblastic nephroma.[4]

Surgery

Surgery is the mainstay of treatment for mesoblastic nephroma.

Primary Prevention

There is no established method for prevention of mesoblastic nephroma.

Secondary Prevention

There are no secondary preventive measures available for mesoblastic nephroma.

References

  1. 1.0 1.1 Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
  2. Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
  3. 3.0 3.1 Furtwaengler R, Reinhard H, Leuschner I, Schenk JP, Goebel U, Claviez A; et al. (2006). “Mesoblastic nephroma–a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH)”. Cancer. 106 (10): 2275–83. doi:10.1002/cncr.21836. PMID 16596620.
  4. 4.0 4.1 4.2 4.3 Malkan AD, Loh A, Bahrami A, et al. (2015). “An approach to renal masses in pediatrics”. Pediatrics. 135 (1): 142–58. doi:10.1542/peds.2014-1011. PMID 25452658.
  5. 5.0 5.1 Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998). “A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma”. Nature Genetics. 18 (2): 184–7. doi:10.1038/ng0298-184. PMID 9462753.
  6. Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
  7. 7.0 7.1 van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C; et al. (2008). “Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups”. Pediatr Blood Cancer. 50 (6): 1130–4. doi:10.1002/pbc.21389. PMID 18095319.
  8. Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
  9. Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
  10. Mesoblastic nephroma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=mesoblastic+nephroma Accessed on November, 3, 2015

Template:WH Template:WS

Historical Perspective

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

References

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Mesoblastic nephroma may be classified according to pathology into three subtypes: classic, cellular, and mixed mesoblastic nephroma.

Classification

Mesoblastic nephroma may be classified according to pathology into three subtypes:[1]

  • Classic mesoblastic nephroma (24%)
  • Cellular mesoblastic nephroma (66%)
  • Mixed mesoblastic nephroma (10%)

References

  1. Malkan AD, Loh A, Bahrami A, et al. (2015). “An approach to renal masses in pediatrics”. Pediatrics. 135 (1): 142–58. doi:10.1542/peds.2014-1011. PMID 25452658.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

On gross pathology, a solid nonencapsulated mass that often occurs near the renal hilum is the characteristic finding of mesoblastic nephroma. On microscopic histopathological analysis, spindle cell is the characteristic finding of classic mesoblastic nephroma; whereas, plump cells with vesicular nuclei is the characteristic finding of cellular mesoblastic nephroma.[1]

Genetics

  • Translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene is involved in the pathogenesis of mesoblastic nephroma.[2]

Gross Pathology

Characteristic findings of mesoblastic nephroma include:[3]

  • Solid nonencapsulated mass
  • Often occurs near the renal hilum
  • Tends to invade the surrounding structures and renal parenchyma
  • Hemorrhage and necrosis are infrequent

Microscopic Pathology

Classic mesoblastic nephroma[4]

Cellular mesoblastic nephroma

  • Plump cells with vesicular nuclei
  • Well-defined border
  • Mitotically active

Mixed mesoblastic nephroma

  • Both classic pattern and cellular pattern areas are present

References

  1. Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
  2. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998). “A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma”. Nature Genetics. 18 (2): 184–7. doi:10.1038/ng0298-184. PMID 9462753.
  3. Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
  4. Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[1]

Causes

Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[1]

References

  1. 1.0 1.1 Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998). “A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma”. Nature Genetics. 18 (2): 184–7. doi:10.1038/ng0298-184. PMID 9462753.

Template:WH Template:WS

Differentiating Mesoblastic nephroma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Mesoblastic nephroma must be differentiated from rhabdoid tumor, clear cell sarcoma of the kidney, and Wilm’s tumor.

Differential diagnosis

Mesoblastic nephroma must be differentiated from:[1][2][3][4][5][6][7][8][9][10][11]

S.No. Disease Symptoms Signs Diagnosis Comments
Abdominal Pain Hematuria Headache Abdominal mass Abdominal tenderness Ultrasonography CT scan Histology
1. Wilms tumor + + + +
  • Wilms tumor has a triphasic appearance.
  • It is comprised of 3 types of cells:
  • All the 3 types are not required for the diagnosis of Wilms tumor.
  • Primitive tubules and glomeruli are often seen comprised of neoplastic cells.
  • Beckwith and Palmer reported in NWTS the different histopathologic types of Wilms tumor to categorize them based on prognosis.[15]
2. Renal cell carcinoma + + +/- +
  • Ultrasound (US) may be helpful when CT scan results are equivocal. It is noteworthy to mention that not all renal cell carcinomas are detectable on ultrasound.
Both CT and MRI may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of the primary cancer. CT scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with renal cell carcinoma. The histological pattern of renal cell carcinoma depends whether it is papillary, chromophobe or collecting duct renal cell carcinoma.
3. Rhabdoid kidney disease + + +
  • CT scan may be diagnostic of malignant rhabdoid tumor. Findings on CT scan suggestive of malignant rhabdoid tumor include a large, heterogenous, centrally located mass, which is lobulated with individual lobules separated by intervening areas of decreased attenuation, relating to either previous hemorrhage or necrosis. Enhancement is similarly heterogeneous. Calcification is relatively common, observed in 20-50% of cases and is typically linear and tends to outline tumor lobules.
  • Malignant rhabdoid tumor is characterized by the round blue tumor cells of high cellularity composed of atypical cells with eccentric nuclei, small nucleoli, and abundant amounts of eosinophilic cytoplasm with frequent mitotic figures.
4. Polycystic kidney disease + + + (from hypertension) +

Ultrasound may be helpful in the diagnosis of polycystic kidney disease. Findings on an ultrasound diagnostic of polycystic kidney disease include:[16][17]

  • At least three unilateral or bilateral cysts in patients 15 – 39 years old
  • Atleast two cysts in each kidney in patients 40 – 59 years old
  • Atleast four cysts in each kidney in patients 60 years of age or older

Renal CT scan may be helpful in the diagnosis of polycystic kidney disease. Findings on CT scan diagnostic of ADPKD include:

  • Numerous renal cysts of varying size and shape with little intervening parenchyma with water attenuation and very thin wall.
  • Reduction in sinus fat due to expansion of the cortex
  • Occasional complex cysts with hyperdense appearance, with possible septations or calcifications
  • Multiple homogeneous and hypoattenuating cystic lesions in the liver in patients with liver involvement
  • On microscopic histopathological analysis, interstitial fibrosis, tubular atrophy, thickening and lamellation of tubular basement membranes, microcysts and negative immunofluorescence for complement and immunoglobulin are characteristic findings of ADPKD.[18][19][20][21]
5. Pheochromocytoma + (as a part of the hypertension paroxysm)
  • CT is the preferred imaging modality for the diagnosis of pheochromocytoma.
The following findings may be observed on CT scan:[22]
  • On microscopic pathology, Pheochromocytoma typically demonstrates a nesting (Zellballen) pattern on microscopy. This pattern is composed of well-defined clusters of tumor cells containing eosinophilic cytoplasm separated by fibrovascular stroma.
6. Burkitt lymphoma +/- (in non-endemic or sporadic form of the disease)
  • On microscopic histopathological analysis, characteristic findings of Burkitt’s lymphoma include:[27]
  • Medium-sized (~1.5-2x the size of a RBC) with uniform size (“monotonous”) — key feature (i.e. tumor nuclei size similar to that of histiocytes or endothelial cells)
  • Round nucleus
  • Small nucleoli
  • Relatively abundant cytoplasm (basophilic)
  • Brisk mitotic rate and apoptotic activity
  • Cellular outline usually appears squared off
  • “Starry-sky pattern”:
  • The stars in the pattern are tingible-body macrophages (macrophages containing apoptotic tumor cells.
  • The tumour cells are the sky
7. Intussusception + +/- +
  • Ultrasound is the gold standard imaging modality used to diagnose intussusception[28]
    • Target or doughnut sign[29]
      • Edematous intussuscipien forms an external ring around the centrally located intussusceptum
      • Target sign is usually seen in right lower quadrant
    • Layers of intussusception forms pseudo-kidney appearance on the transverse view
  • CT scan may be helpful in the diagnosis of intussusception. CT scan maybe used when other image modalities like x-ray and ultrasound have not given positive results but suspicion of intussusception is high.
  • Intussusception occurs if there is an imbalance between the longitudinal and radial smooth muscle forces of intestine that maintain its normal structure. This imbalance leads to a segment of intestine to invaginate into another segment and cause entero-enteral intussusception. Etiology of intussusception is either idiopathic or pathologic (lead point). 
8. Hydronephrosis + +/- + (CVA tenderness in case of pyelonephritis)
  • In the case of renal colic (one sided loin pain usually accompanied by a trace of blood in the urine) the initial investigation is usually an intravenous urogram. This has the advantage of showing whether there is any obstruction of flow of urine causing hydronephrosis as well as demonstrating the function of the other kidney. Many stones are not visible on plain x ray or IVU but 99% of stones are visible on CT and therefore CT is becoming a common choice of initial investigation.
  • The kidney undergoes extensive dilation with atrophy and thinning of the renal cortex.
9. Dysplastic kidney N/A N/A N/A N/A N/A

MCDK is usually diagnosed by ultrasound examination before birth.

  • Mass of non-communicating cysts of variable size.
  • Unlike severe hydronephrosis, in which the largest cystic structure (the renal pelvis) lies in a central location and is surrounded by dilated calices, in multicystic dysplastic kidney the cyst distribution shows no recognizable pattern.
  • Dysplastic, echogenic parenchyma may be visible between the cysts, but no normal renal parenchyma is seen.
  • MCKD can be discovered accidentally on CT scan.
  • CT scan shows myltiple cysts with absence of renal parenchyma.
  • MCKD is the result of abnormal differentiation of the renal parenchyma.
10. Pediatric Neuroblastoma + +/- +/-
  • CT scan is the investigation of choice for the diagnosis of neuroblastoma.[31]
  • On CT scan, neuroblastoma is characterized by:[32]
  • On microscopic histopathological analysis the presence of round blue cells separated by thin fibrous septa are characteristic findings of neuroblastoma.
  • Other findings of neuroblastoma on light microscopy may include:[33]
  • Homer-Wright rosettes (rosettes with a small meshwork of fibers at the center)
  • Neuropil-like stroma (paucicellular stroma with a cotton candy-like appearance)
11. Pediatric Rhabdomyosarcoma + +/- +/- +/- On CT scan, rhabdomyosarocma is characterized by:
  • Soft tissue density
  • Some enhancement with contrast
  • Adjacent bony destruction (over 20% of cases)
12. Mesoblastic nephroma + + +
  • Ultrasound may be helpful in the diagnosis of mesoblastic nephroma.
  • Mesoblastic nephroma may presents as a well-defined mass with low-level homogeneous echoes.[34]
  • The presence of concentric echogenic and hypoechoic rings can be a helpful diagnostic feature of mesoblastic nephroma.
  • CT scan may be helpful in the diagnosis of mesoblastic nephroma.
  • Findings on CT scan suggestive of mesoblastic nephroma include:
  • Solid hypoattenuating renal lesion
  • Variable contrast enhancement
  • No calcification

Classic mesoblastic nephroma

Cellular mesoblastic nephroma

  • Plump cells with vesicular nuclei
  • Well-defined border
  • Mitotically active

Mixed mesoblastic nephroma

  • Both classic pattern and cellular pattern areas are present
Most common renal tumor that occurs in 1st month of life

References

  1. Mesoblastic nephroma. Wikipedia 2015. https://en.wikipedia.org/wiki/Mesoblastic_nephroma
  2. Garnier S, Maillet O, Haouy S, Saguintaah M, Serre I, Galifer RB; et al. (2012). “Prenatal intrarenal neuroblastoma mimicking a mesoblastic nephroma: a case report”. J Pediatr Surg. 47 (8): e21–3. doi:10.1016/j.jpedsurg.2012.03.090. PMID 22901938.
  3. D. S. Hartman & R. C. Sanders (1982). “Wilms’ tumor versus neuroblastoma: usefulness of ultrasound in differentiation”. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 1 (3): 117–122. PMID 6152936. Unknown parameter |month= ignored (help)
  4. J. F. De Campo (1986). “Ultrasound of Wilms’ tumor”. Pediatric radiology. 16 (1): 21–24. PMID 3003660.
  5. Sara E. Wobker & Sean R. Williamson (2017). “Modern Pathologic Diagnosis of Renal Oncocytoma”. Journal of kidney cancer and VHL. 4 (4): 1–12. doi:10.15586/jkcvhl.2017.96. PMID 29090117.
  6. Bita Geramizadeh, Mahmoud Ravanshad & Marjan Rahsaz (2008). “Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma”. Indian journal of pathology & microbiology. 51 (2): 167–171. PMID 18603673. Unknown parameter |month= ignored (help)
  7. Oleksandr N. Kryvenko, Merce Jorda, Pedram Argani & Jonathan I. Epstein (2014). “Diagnostic approach to eosinophilic renal neoplasms”. Archives of pathology & laboratory medicine. 138 (11): 1531–1541. doi:10.5858/arpa.2013-0653-RA. PMID 25357116. Unknown parameter |month= ignored (help)
  8. A. M. Amar, G. Tomlinson, D. M. Green, N. E. Breslow & P. A. de Alarcon (2001). “Clinical presentation of rhabdoid tumors of the kidney”. Journal of pediatric hematology/oncology. 23 (2): 105–108. PMID 11216700. Unknown parameter |month= ignored (help)
  9. T. I. Han, M. J. Kim, H. K. Yoon, J. Y. Chung & K. Choeh (2001). “Rhabdoid tumour of the kidney: imaging findings”. Pediatric radiology. 31 (4): 233–237. doi:10.1007/s002470000417. PMID 11321739. Unknown parameter |month= ignored (help)
  10. S. L. Gooskens, M. E. Houwing, G. M. Vujanic, J. S. Dome, T. Diertens, A. Coulomb-l’Hermine, J. Godzinski, K. Pritchard-Jones, N. Graf & M. M. van den Heuvel-Eibrink (2017). “Congenital mesoblastic nephroma 50 years after its recognition: A narrative review”. Pediatric blood & cancer. 64 (7). doi:10.1002/pbc.26437. PMID 28124468. Unknown parameter |month= ignored (help)
  11. Zuo-Peng Wang, Kai Li, Kui-Ran Dong, Xian-Min Xiao & Shan Zheng (2014). “Congenital mesoblastic nephroma: Clinical analysis of eight cases and a review of the literature”. Oncology letters. 8 (5): 2007–2011. doi:10.3892/ol.2014.2489. PMID 25295083. Unknown parameter |month= ignored (help)
  12. Hartman DS, Sanders RC (April 1982). “Wilms’ tumor versus neuroblastoma: usefulness of ultrasound in differentiation”. J Ultrasound Med. 1 (3): 117–22. PMID 6152936.
  13. De Campo JF (1986). “Ultrasound of Wilms’ tumor”. Pediatr Radiol. 16 (1): 21–4. PMID 3003660.
  14. Cahan LD (1985). “Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease”. Pediatr Neurosci. 12 (1): 58–62. PMID 4080660.
  15. Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN (November 1975). “Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases”. Adv Vet Sci Comp Med. 19 (23): 1–21. PMID 1978.
  16. Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC (July 2015). “Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference”. Kidney Int. 88 (1): 17–27. doi:10.1038/ki.2015.59. PMC 4913350. PMID 25786098.
  17. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D (January 2009). “Unified criteria for ultrasonographic diagnosis of ADPKD”. J. Am. Soc. Nephrol. 20 (1): 205–12. doi:10.1681/ASN.2008050507. PMC 2615723. PMID 18945943.
  18. Stavrou C, Koptides M, Tombazos C, Psara E, Patsias C, Zouvani I, Kyriacou K, Hildebrandt F, Christofides T, Pierides A, Deltas CC (October 2002). “Autosomal-dominant medullary cystic kidney disease type 1: clinical and molecular findings in six large Cypriot families”. Kidney Int. 62 (4): 1385–94. doi:10.1111/j.1523-1755.2002.kid581.x. PMID 12234310.
  19. Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ, Hodanová K, Vylet’al P, Živná M, Hart TC, Hart PS (March 2014). “Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1”. Clin J Am Soc Nephrol. 9 (3): 527–35. doi:10.2215/CJN.06380613. PMC 3944763. PMID 24509297.
  20. Faguer S, Decramer S, Chassaing N, Bellanné-Chantelot C, Calvas P, Beaufils S, Bessenay L, Lengelé JP, Dahan K, Ronco P, Devuyst O, Chauveau D (October 2011). “Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood”. Kidney Int. 80 (7): 768–76. doi:10.1038/ki.2011.225. PMID 21775974.
  21. Heidet L, Decramer S, Pawtowski A, Morinière V, Bandin F, Knebelmann B, Lebre AS, Faguer S, Guigonis V, Antignac C, Salomon R (June 2010). “Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases”. Clin J Am Soc Nephrol. 5 (6): 1079–90. doi:10.2215/CJN.06810909. PMC 2879303. PMID 20378641.
  22. Bravo EL (1991). “Pheochromocytoma: new concepts and future trends”. Kidney Int. 40 (3): 544–56. PMID 1787652.
  23. Whalen RK, Althausen AF, Daniels GH (1992). “Extra-adrenal pheochromocytoma”. J Urol. 147 (1): 1–10. PMID 1729490.
  24. Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJ, Adams KT; et al. (2009). “Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma”. Ann Intern Med. 150 (1): 27–32. PMC 3490128. PMID 19124817.
  25. Bravo EL (1991). “Pheochromocytoma: new concepts and future trends”. Kidney Int. 40 (3): 544–56. PMID 1787652.
  26. Burkitt lymphoma. MedlinePlus. https://www.nlm.nih.gov/medlineplus/ency/article/001308.htm Accessed on September 30, 2015
  27. Bellan C, Lazzi S, De Falco G, Nyongo A, Giordano A, Leoncini L (2003). “Burkitt’s lymphoma: new insights into molecular pathogenesis”. J. Clin. Pathol. 56 (3): 188–92. PMC 1769902. PMID 12610094. Unknown parameter |month= ignored (help)
  28. Ko HS, Schenk JP, Tröger J, Rohrschneider WK (2007). “Current radiological management of intussusception in children”. Eur Radiol. 17 (9): 2411–21. doi:10.1007/s00330-007-0589-y. PMID 17308922.
  29. Boyle MJ, Arkell LJ, Williams JT (1993). “Ultrasonic diagnosis of adult intussusception”. Am. J. Gastroenterol. 88 (4): 617–8. PMID 8470658.
  30. Neuroblastoma. Radiopaedia (2015) http://radiopaedia.org/articles/neuroblastoma Accessed on October, 8 2015
  31. Colon NC, Chung DH (2011). “Neuroblastoma”. Adv Pediatr. 58 (1): 297–311. doi:10.1016/j.yapd.2011.03.011. PMC 3668791. PMID 21736987.
  32. Neuroblastoma. Radiopaedia (2015) http://radiopaedia.org/articles/neuroblastoma Accessed on October, 8 2015
  33. Neuroblastoma. Libre Pathology(2015) http://librepathology.org/wiki/index.php/Adrenal_gland#Neuroblastoma Accessed on October, 5 2015
  34. Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates. [1][2] The male to female ratio is approximately 2 to 1.[3]

Epidemiology and Demographics

Prevalence

Mesoblastic nephroma accounts for approximately 3-6% of all renal neoplams in children.[1]

Age

Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates. [1][4]

Gender

Boys are more commonly affected with mesoblastic nephroma than girls. The male to female ratio is approximately 2 to 1.[3]

References

  1. 1.0 1.1 1.2 Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
  2. Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
  3. 3.0 3.1 Furtwaengler R, Reinhard H, Leuschner I, Schenk JP, Goebel U, Claviez A; et al. (2006). “Mesoblastic nephroma–a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH)”. Cancer. 106 (10): 2275–83. doi:10.1002/cncr.21836. PMID 16596620.
  4. Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

There are no established risk factors for mesoblastic nephroma.

Risk Factors

There are no established risk factors for mesoblastic nephroma.

References

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for mesoblastic nephroma.[1]

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for mesoblastic nephroma.[2]

References

  1. Mesoblastic nephroma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=mesoblastic+nephroma Accessed on November, 3, 2015
  2. Mesoblastic nephroma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=mesoblastic+nephroma Accessed on November, 3, 2015

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Complications of mesoblastic nephroma include stillbirth, shoulder dystocia at birth, hydrops fetalis, and respiratory distress syndrome. Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[1]

Complications

Potential complications of mesoblastic nephroma include:[2][3][4]

Prognosis

  • Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[1]

References

  1. 1.0 1.1 van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C; et al. (2008). “Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups”. Pediatr Blood Cancer. 50 (6): 1130–4. doi:10.1002/pbc.21389. PMID 18095319.
  2. Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
  3. Leclair MD, El-Ghoneimi A, Audry G, Ravasse P, Moscovici J, Heloury Y; et al. (2005). “The outcome of prenatally diagnosed renal tumors”. J Urol. 173 (1): 186–9. PMID 15592071.
  4. Liu YC, Mai YL, Chang CC, Chen KW, Chow SN (1996). “The presence of hydrops fetalis in a fetus with congenital mesoblastic nephroma”. Prenat Diagn. 16 (4): 363–5. doi:10.1002/(SICI)1097-0223(199604)16:4<363::AID-PD858>3.0.CO;2-O. PMID 8734816.

Template:WH Template:WS

Diagnosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy

Treatment

Treatment

Medical therapy | Surgery | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Template:WH Template:WS

Template:Urologic neoplasia


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH